News

Since April, the Tumor Center CCC Tübingen-Stuttgart has been headed by Prof. Sara Brucker (Department of Women's Health Tübingen). Prof. Ghazaleh...

The Hertie Institute for Clinical Brain Research (HIH) as part of the Center of Neurology of the University of Tübingen has been chosen by The Michael...

Bringing basic scientists and clinical researchers closer together and promoting their exchange of knowledge and expertise: These are the goals of the...

In the podcast "Mit Herz und Hirn" ("With Heart and Brain") by Frankfurter Allgemeine Zeitung and Hertie Foundation, Professor Dr. Thomas Gasser talks...

Bruce Willis recently ended his acting career due to a diagnosed aphasia. In an interview with the Hertie Foundation, Professor Dr. Ulf Ziemann...

On the occasion of World Parkinson's Day on April 11, Dr. Daniel Weiß explains in an interview with the Hertie Foundation why early treatment of the...

A new Phase 1 study is investigating the tolerability of the PD1 antibody Nivolumab in the treatment of meningioma neoplastica. For the first time,...

The Else Kröner Fresenius Foundation (EKFS) will continue to fund the research school “Therapy Resistance of Solid Tumors” until the end of 2024. The...

A small piece of nucleic acid could be the key to success: With its help, a Tübingen research team has succeeded in repairing a gene defect directly...

Dravet syndrome is one of the most common severe forms of early childhood epilepsy.
Fortunately, the disease is very rare; in Germany, only one in...